Page last updated: 2024-08-21

arsenic trioxide and Pleural Effusion

arsenic trioxide has been researched along with Pleural Effusion in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
de Botton, S; DiNardo, CD; Fathi, AT; Levis, MJ; Montesinos, P; Stein, EM	1
Hangaishi, A; Ichikawa, M; Kaise, T; Kumano, K; Kurokawa, M; Miyashita, SI; Nagai, S; Nannya, Y; Ueda, K	1
Antonioli, E; Cas, LD; D'Aloia, A; Raddino, R; Vizzardi, E; Zanini, G	1
Hayashi, T; Imanaka, T; Ishii, K; Komatsu, H; Nakamura, F; Ono, Y; Sawada, H; Tanaka, Y	1
Camacho, LH; Chanel, S; Ellison, R; Heller, G; Ho, R; Scheinberg, DA; Soignet, SL; Warrell, RP	1

Reviews

1 review(s) available for arsenic trioxide and Pleural Effusion

Article	Year
Differentiation syndrome with lower-intensity treatments for acute myeloid leukemia. American journal of hematology, 2021, 06-01, Volume: 96, Issue:6 Topics: Acute Kidney Injury; Adrenal Cortex Hormones; Antineoplastic Agents; Arsenic Trioxide; Cell Differentiation; Clinical Trials as Topic; Cytokine Release Syndrome; Edema; Enzyme Inhibitors; Epigenesis, Genetic; Fever; fms-Like Tyrosine Kinase 3; Humans; Hypotension; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Molecular Targeted Therapy; Myelopoiesis; Neoplasm Proteins; Pleural Effusion; Respiration Disorders; Tretinoin	2021

Article

Year

Differentiation syndrome with lower-intensity treatments for acute myeloid leukemia.

American journal of hematology, 2021, 06-01, Volume: 96, Issue:6

Topics: Acute Kidney Injury; Adrenal Cortex Hormones; Antineoplastic Agents; Arsenic Trioxide; Cell Differentiation; Clinical Trials as Topic; Cytokine Release Syndrome; Edema; Enzyme Inhibitors; Epigenesis, Genetic; Fever; fms-Like Tyrosine Kinase 3; Humans; Hypotension; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Molecular Targeted Therapy; Myelopoiesis; Neoplasm Proteins; Pleural Effusion; Respiration Disorders; Tretinoin

2021

Other Studies

4 other study(ies) available for arsenic trioxide and Pleural Effusion

Article	Year
Arsenic-induced pericardial and pleural effusion without acute promyelocytic leukemia differentiation syndrome. Leukemia research, 2010, Volume: 34, Issue:1 Topics: Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Humans; Leukemia, Promyelocytic, Acute; Male; Oxides; Pericardial Effusion; Pleural Effusion	2010
QT prolongation: a case of arsenical pericardial and pleural effusion. Cardiovascular toxicology, 2008, Volume: 8, Issue:1 Topics: Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Humans; Leukemia, Promyelocytic, Acute; Long QT Syndrome; Male; Oxides; Pericardial Effusion; Pleural Effusion; Recovery of Function; Withholding Treatment	2008
[Successful treatment of relapsed and refractory acute promyelocytic leukemia with arsenic trioxide (As2O3)]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2000, Volume: 41, Issue:4 Topics: Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Drug Resistance, Neoplasm; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Male; Neoplasm Recurrence, Local; Oxides; Pleural Effusion; Remission Induction; Treatment Outcome; Tretinoin	2000
Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:13 Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Dyspnea; Fever; Humans; Leukemia, Promyelocytic, Acute; Leukocytosis; Oxides; Pleural Effusion; Syndrome; Tretinoin	2000